Drug - resistant multiple myeloma. A trial with the M 2 cyclic alkylating agent polychemotherapy.
作者信息
Buonanno G, Tortarolo M, Valente A, Castaldo C, Russolillo S, Gonnella F
出版信息
Haematologica. 1978 Feb;63(1):45-55.
PMID:417971
Abstract
摘要
相似文献
1
Drug - resistant multiple myeloma. A trial with the M 2 cyclic alkylating agent polychemotherapy.耐药性多发性骨髓瘤。一项使用M2环烷基化剂联合化疗的试验。
Haematologica. 1978 Feb;63(1):45-55.
2
An overview of the status of the nitrosoureas in other tumors.亚硝基脲类药物在其他肿瘤中的应用现状综述。
Cancer Chemother Rep 3. 1973 May;4(3):35-46.
3
Effective treatment of advanced multiple myeloma refractory to alkylating agents.对烷化剂难治的晚期多发性骨髓瘤的有效治疗。
N Engl J Med. 1984 May 24;310(21):1353-6. doi: 10.1056/NEJM198405243102104.
4
[Combination chemotherapy (modified M-2 protocol) for multiple myeloma].
Rinsho Ketsueki. 1984 Sep;25(9):1380-7.
5
[Chemotherapy of multiple myeloma. Review of the recent trials].[多发性骨髓瘤的化疗。近期试验综述]
Recenti Prog Med. 1981 Aug;71(2):141-7.
6
[Treatment of Kahler's disease].
Sem Hop. 1976 Jan 16;52(3):165-71.
7
Treatment of plasma cell myeloma with cytotoxic agents.
Arch Intern Med. 1975 Jan;135(1):172-6.
8
[Recent progress in chemotherapy of multiple myeloma].
Recenti Prog Med. 1978 Jul;65(1):44-68.
9
Proceedings: Combination chemotherapy of multiple myeloma with alkeran, cytoxan, vincristine, prednisone, and BCNU.研究报告：美法仑、环磷酰胺、长春新碱、泼尼松和卡氮芥联合化疗多发性骨髓瘤
Cancer. 1974 Feb;33(2):533-8. doi: 10.1002/1097-0142(197402)33:2<533::aid-cncr2820330231>3.0.co;2-z.
10
Remission maintenance therapy for multiple myeloma.多发性骨髓瘤的缓解维持治疗
Arch Intern Med. 1975 Jan;135(1):147-52.
引用本文的文献
1
Melphalan-resistant multiple myeloma: results of treatment according to the M-2 protocol.
Cancer Chemother Pharmacol. 1985;14(3):279-81. doi: 10.1007/BF00258135.
Zotero 插件